Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THOMAS E SCAMMELL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1194762724
CMS profile
144878
Location
BOSTON, MA

General Payments · PY2018–2024

$551,228.29

  • Reported across 146 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$71,120.88

19 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $60,346.60 12
Travel and Lodging $10,239.25 2
Food and Beverage $535.03 5

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $65,400.05 11
HARMONY BIOSCIENCES LLC $3,288.00 2
Avadel CNS Pharmaceuticals, LLC $2,250.00 5
JAZZ PHARMACEUTICALS INC. $182.83 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $42,384.94 19
PY2019 $64,998.77 32
PY2020 $35,920.00 11
PY2021 $110,603.95 18
PY2022 $114,130.56 24
PY2023 $112,069.19 23
PY2024 $71,120.88 19

Payment records · PY2024 (19)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Avadel CNS Pharmaceuticals, LLC $500.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1123387728 CMS
Avadel CNS Pharmaceuticals, LLC $250.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1123387730 CMS
Avadel CNS Pharmaceuticals, LLC $500.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1123387732 CMS
Avadel CNS Pharmaceuticals, LLC $500.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 1123387734 CMS
Avadel CNS Pharmaceuticals, LLC $500.00 08/20/2024 Consulting Fee Undisputed 01/23/2026 1123387736 CMS
HARMONY BIOSCIENCES LLC $1,563.00 04/11/2024 Consulting Fee Undisputed 01/23/2026 1126071432 CMS
HARMONY BIOSCIENCES LLC $1,725.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1126071430 CMS
JAZZ PHARMACEUTICALS INC. $182.83 06/02/2024 Food and Beverage Undisputed 01/23/2026 1150203796 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15,450.00 04/08/2024 Consulting Fee Undisputed 01/23/2026 1137669124 CMS
Takeda Pharmaceuticals U.S.A., Inc. $85.65 06/01/2024 Food and Beverage Undisputed 01/23/2026 1137669126 CMS
Takeda Pharmaceuticals U.S.A., Inc. $145.91 06/04/2024 Food and Beverage Undisputed 01/23/2026 1137669128 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16,740.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 1137669130 CMS
Takeda Pharmaceuticals U.S.A., Inc. $663.53 09/24/2024 Travel and Lodging Undisputed 01/23/2026 1137669132 CMS
Takeda Pharmaceuticals U.S.A., Inc. $55.43 09/24/2024 Food and Beverage Undisputed 01/23/2026 1137669134 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9,575.72 09/24/2024 Travel and Lodging Undisputed 01/23/2026 1137669136 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13,548.60 09/24/2024 Consulting Fee Undisputed 01/23/2026 1137669138 CMS
Takeda Pharmaceuticals U.S.A., Inc. $65.21 09/24/2024 Food and Beverage Undisputed 01/23/2026 1137669140 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,175.00 11/04/2024 Consulting Fee Undisputed 01/23/2026 1137669142 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,895.00 11/08/2024 Consulting Fee Undisputed 01/23/2026 1137669144 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.